These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11678786)

  • 1. Curtailing unnecessary vancomycin usage in a hospital with high rates of methicillin resistant Staphylococcus aureus infections.
    Kumana CR; Ching TY; Kong Y; Ma EC; Kou M; Lee RA; Cheng VC; Chiu SS; Seto WH
    Br J Clin Pharmacol; 2001 Oct; 52(4):427-32. PubMed ID: 11678786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
    Huang JH; Hsu RB
    Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin use in a hospital with high prevalence of methicillin-resistant Staphylococcus aureus: comparison with Hospital Infection Control Practices Advisory Committe Guidelines (HICPAC).
    Melo DO; Sasaki M; Grinbaum RS
    Braz J Infect Dis; 2007 Feb; 11(1):53-6. PubMed ID: 17625728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use.
    Garrouste-Orgeas M; Timsit JF; Kallel H; Ben Ali A; Dumay MF; Paoli B; Misset B; Carlet J
    Infect Control Hosp Epidemiol; 2001 Nov; 22(11):687-92. PubMed ID: 11842988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
    Sipahi OR; Arda B; Yurtseven T; Sipahi H; Ozgiray E; Suntur BM; Ulusoy S
    Int J Antimicrob Agents; 2005 Nov; 26(5):412-5. PubMed ID: 16221540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital.
    Mallaval FO; Carricajo A; Delavenna F; Recule C; Fonsale N; Manquat G; Raffenot D; Rogeaux O; Aubert G; Tous J
    Clin Microbiol Infect; 2004 May; 10(5):459-61. PubMed ID: 15113326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycopeptide-induced vasculitis--cross-reactivity between vancomycin and teicoplanin.
    Marshall C; Street A; Galbraith K
    J Infect; 1998 Jul; 37(1):82-3. PubMed ID: 9733391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
    Cartolano GL; Cheron M; Benabid D; Leneveu M; Boisivon A;
    Clin Microbiol Infect; 2004 May; 10(5):448-51. PubMed ID: 15113324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A closer look at vancomycin, teicoplanin, and antimicrobial resistance.
    Zeckel ML
    J Chemother; 1997 Oct; 9(5):311-31; discussion 332-5. PubMed ID: 9373787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
    Drago L; De Vecchi E; Nicola L; Gismondo MR
    BMC Infect Dis; 2007 Sep; 7():111. PubMed ID: 17888153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.
    Van Laethem Y; Hermans P; De Wit S; Goosens H; Clumeck N
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():81-7. PubMed ID: 2965135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of vancomycin and teicoplanin in the treatment of hospitalised elderly patients with persistent meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia.
    Lin SH; Lai CC; Tan CK; Liao WH; Hsueh PR
    Int J Antimicrob Agents; 2011 Feb; 37(2):179-81. PubMed ID: 21163634
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of glycopeptides in the treatment of infections caused by methicillin-resistant staphylococci].
    Bouza E; Rodríguez-Créixems M; Muñoz P
    Rev Clin Esp; 1997 Sep; 197 Suppl 2():52-8. PubMed ID: 9441324
    [No Abstract]   [Full Text] [Related]  

  • 15. Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983-2002.
    Robert J; Bismuth R; Jarlier V
    J Antimicrob Chemother; 2006 Mar; 57(3):506-10. PubMed ID: 16410265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA).
    Gould IM
    Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S17-21. PubMed ID: 23664580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiulcer drug prescribing in hospital successfully influenced by "immediate concurrent feedback".
    Kumana CR; Ching TY; Cheung E; Kong Y; Kou M; Chan CK; Chu KM; Seto WH; Lam SK
    Clin Pharmacol Ther; 1998 Nov; 64(5):569-74. PubMed ID: 9834050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.
    Peeters O; Ferry T; Ader F; Boibieux A; Braun E; Bouaziz A; Karsenty J; Forestier E; Laurent F; Lustig S; Chidiac C; Valour F;
    BMC Infect Dis; 2016 Nov; 16(1):622. PubMed ID: 27809799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus.
    Vaudaux P; Francois P; Berger-Bächi B; Lew DP
    J Antimicrob Chemother; 2001 Feb; 47(2):163-70. PubMed ID: 11157900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.